Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
IRF8 |
interferon regulatory factor 8 |
Mapped by significant region |
|
IL6 |
interleukin 6 (interferon, beta 2) |
Mapped by significant region |
IDA[2261637]
|
MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
|
UBE2L6 |
ubiquitin-conjugating enzyme E2L 6 |
Mapped by significant region |
|
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
Mapped by CNV |
|
RNASEL |
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) |
Mapped by significant region |
|
KPNA5 |
karyopherin alpha 5 (importin alpha 6) |
Mapped by CNV; Mapped by significant region |
|
IRF9 |
interferon regulatory factor 9 |
Mapped by significant region |
|
NUP62 |
nucleoporin 62kDa |
Mapped by PBA pathway |
|
PTPRN |
protein tyrosine phosphatase, receptor type, N |
Mapped by significant region |
|
HERC5 |
hect domain and RLD 5 |
Mapped by CNV |
|
CLCF1 |
cardiotrophin-like cytokine factor 1 |
Mapped by significant region |
NAS[10500198]
|
DUOX2 |
dual oxidase 2 |
Mapped by CNV |
IDA[16111680]
|
IRF7 |
interferon regulatory factor 7 |
Mapped by LD-proxy |
|
UBB |
ubiquitin B |
Mapped by significant region |
|
RQCD1 |
RCD1 required for cell differentiation1 homolog (S. pombe) |
Mapped by significant region |
|
UBC |
ubiquitin C |
Mapped by CNV |
|
LIFR |
leukemia inhibitory factor receptor alpha |
Mapped by significant region |
IDA[7957045]
|
DUOX1 |
dual oxidase 1 |
Mapped by CNV |
IDA[16111680]
|
IFNGR1 |
interferon gamma receptor 1 |
Mapped by significant region |
|
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
Mapped by significant region |
IDA[15876188]
|
NCAM1 |
neural cell adhesion molecule 1 |
Mapped by significant region |
|
NUPL2 |
nucleoporin like 2 |
Mapped by CNV; Mapped by significant region |
|
NUP155 |
nucleoporin 155kDa |
Mapped by significant region |
|
OASL |
2'-5'-oligoadenylate synthetase-like |
Mapped by PBA pathway |
|